Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine 10 mg in persistent allergic rhinitis
2006-003108-20Phase 2Completed
- Sponsor
- Uriach
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in persistent allergic rhinitis (PAR) comparing Rupafin with Placebo (2 arms). Started Jan 2007; status: completed.
02
Drugs
rupatadine
03
Conditions
persistent allergic rhinitis (PAR)
Beyond the preview
Go deeper on 2006-003108-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003108-20.